The GLP-1 Revolution: What Employers Need to Know About Coverage, Cost, and Compliance

Once known primarily as diabetes medications, GLP-1 drugs have rapidly become one of the most disruptive forces in employer-sponsored healthcare.

Medications such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are reshaping conversations around obesity treatment, chronic disease management, workforce wellness, and long-term healthcare spending. What began as a clinical breakthrough has quickly evolved into a strategic business issue - one that employers can no longer afford to ignore.

As demand surges and prescription utilization accelerates, employers across the country are weighing a difficult question: Should health plans cover GLP-1 medications for weight loss - and if so, how? The answer is far from simple.

A Growing Demand with Significant Financial Implications

According to KFF’s 2025 Employer Health Benefits Survey, nearly 20% of large employers now provide coverage for GLP-1 medications when prescribed primarily for weight loss. Among the nation’s largest employers (those with more than 5,000 employees) that number climbs dramatically to 43%.

But the expansion of coverage has come at a cost.

Many employers report that GLP-1 utilization has become one of the fastest-growing drivers of prescription drug spending. In fact, nearly two-thirds of the largest employers offering coverage said the medications had a “significant” financial impact on their health plan costs.

The challenge lies in the unique nature of these medications:

• Monthly treatment costs can exceed $1,000 per member;

• Clinical demand continues to rise;

• Obesity impacts a substantial percentage of the workforce; and

• Many patients may require long-term or indefinite treatment to maintain results.

For employers already navigating rising healthcare expenses, GLP-1 coverage decisions have become a balancing act between employee well-being, talent retention, and financial sustainability.

Why GLP-1s Are Different

Unlike many traditional wellness initiatives, GLP-1 medications have demonstrated measurable clinical outcomes.

Research continues to show meaningful reductions in:

• Body weight;

• Cardiovascular risk;

• Diabetes progression;

• Hypertension; and

• Other obesity-related chronic conditions.

This has shifted obesity treatment from a lifestyle conversation to a legitimate medical management strategy.

As a result, employers are increasingly viewing obesity not simply as a wellness issue, but as a chronic condition with direct implications for productivity, absenteeism, disability claims, and long-term medical costs.

The result? Employers are moving beyond a simple “cover or exclude” decision and instead building more nuanced strategies around access, accountability, and clinical oversight.

Employers Are Adding Guardrails to Coverage

To manage utilization and improve outcomes, many employers offering GLP-1 coverage are implementing structured requirements tied to treatment eligibility.

KFF reports that approximately one-third of employers covering GLP-1s now require participants to engage in additional support programs, such as:

• Nutritional counseling;

• Lifestyle coaching;

• Case management;

• Behavioral therapy; or

• Physician-supervised weight management programs.

These guardrails are designed to:

• Encourage sustainable health outcomes;

• Improve medication adherence;

• Reduce inappropriate utilization; and

• Support broader population health objectives.

For many organizations, the goal is not simply to approve prescriptions - but to create a clinically integrated obesity management strategy.

The Legal Landscape Is Still Evolving

While employers generally maintain discretion over health plan design, GLP-1 coverage decisions are increasingly intersecting with federal nondiscrimination laws.

Currently, no broad federal mandate requires employer-sponsored health plans to cover GLP-1 medications for obesity treatment. However, the legal environment continues to evolve as obesity-related discrimination claims gain visibility.

Employers should carefully evaluate potential implications under:

• The Americans with Disabilities Act (ADA);

• HIPAA nondiscrimination rules;

• ACA Section 1557 nondiscrimination requirements; and

• The Mental Health Parity and Addiction Equity Act (MHPAEA).

Although courts have historically differed on whether obesity alone constitutes a disability under the ADA, legal interpretations continue to develop. In addition, regulators and plaintiffs are increasingly scrutinizing indication-based exclusions - such as covering GLP-1s for diabetes treatment while excluding obesity treatment.

The issue becomes even more complex when wellness programs, biometric screenings, or family medical history are involved, potentially triggering additional compliance obligations under HIPAA, the ADA, and the Genetic Information Nondiscrimination Act (GINA).

For employers, consistency and documentation are critical. Health plans should ensure:

• Plan documents accurately reflect coverage rules;

• Utilization management protocols are applied consistently;

• Employee communications are updated promptly; and

• Summary Plan Descriptions (SPDs) and enrollment materials remain aligned with operational practices.

Alternative Strategies Beyond Traditional Coverage

Not every employer is prepared to fully absorb the cost of GLP-1 coverage through its group health plan. As a result, many organizations are exploring alternative approaches that still provide employees with financial support.

Tax-advantaged health accounts including HSAs, FSAs, and HRAs may allow employees to use pre-tax dollars toward GLP-1 medications when prescribed for a diagnosed medical condition such as obesity, diabetes, hypertension, or heart disease.

These strategies can offer employers greater flexibility while helping employees offset out-of-pocket expenses.

However, employers should note an important distinction: GLP-1 medications generally qualify as reimbursable medical expenses only when prescribed to treat a diagnosed disease - not for general wellness, appearance improvement, or non-medical weight loss goals.

Clear plan administration and employee education remain essential.

The Future of Employer Health Strategy

The conversation around GLP-1 medications represents something larger than a prescription trend.

It reflects a broader transformation in how employers approach chronic disease management, preventive care, workforce health, and healthcare affordability.

As utilization grows, organizations will increasingly need to answer difficult strategic questions:

• How should obesity treatment fit within overall population health strategy?

• What level of coverage is financially sustainable?

• How can employers balance access with responsible utilization management?

• And how can benefits programs remain compliant amid a rapidly evolving legal landscape?

There is no universal solution.

But there is growing consensus that employers who proactively evaluate their GLP-1 strategy today will be better positioned to manage healthcare costs, support employee well-being, and remain competitive in tomorrow’s labor market.

Thrive PEO: Helping Employers Navigate Complex Benefits Decisions

As healthcare regulations evolve and benefit costs continue to rise, employers need more than administrative support. They need strategic guidance.

Thrive PEO works hand-in-hand with insurance brokers to help businesses design competitive, compliant, and cost-conscious employee benefits strategies tailored to today’s workforce challenges. From evaluating emerging healthcare trends like GLP-1 coverage to supporting compliance, plan administration, and workforce wellness initiatives, Thrive PEO delivers the expertise employers need to make informed decisions with confidence.

Whether your organization is reassessing pharmacy benefits, enhancing employee wellness offerings, or navigating regulatory complexity, Thrive PEO provides the HR and benefits support necessary to help your business - and your employees - thrive.

Ready to thrive? Contact us today at: (918) 794-2200.

Thrive PEO is a full-service Professional Employer Organization (PEO); and provides a customized suite of human resource solutions designed to help SMBs: lower employee benefit costs, increase productivity and profitability, and reduce employer liabilities and business risks. Services cover the entire employee lifecycle, and include: payroll and tax administration, employee benefits and related administration, HR and compliance, workers’ compensation insurance, retirement plans and more – all delivered via market-leading HRIS technology.